Intracoronary transplantation of pluripotent stem cell-derived cardiomyocytes: Inefficient procedure for cardiac regeneration.

[1]  Y. Tabata,et al.  Intramyocardial Transplantation of Human iPS Cell–Derived Cardiac Spheroids Improves Cardiac Function in Heart Failure Animals , 2021, JACC. Basic to translational science.

[2]  Lauren E. Neidig,et al.  Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes , 2021, bioRxiv.

[3]  K. Fukuda,et al.  Tryptophan Metabolism Regulates Proliferative Capacity of Human Pluripotent Stem Cells , 2021, iScience.

[4]  Y. Shiba.  Pluripotent Stem Cells for Cardiac Regeneration　- Current Status, Challenges, and Future Perspectives. , 2020, Circulation journal : official journal of the Japanese Circulation Society.

[5]  K. Wollert,et al.  Continuous WNT Control Enables Advanced hPSC Cardiac Processing and Prognostic Surface Marker Identification in Chemically Defined Suspension Culture , 2019, Stem cell reports.

[6]  G. Wright,et al.  Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias , 2019, Stem cell reports.

[7]  Y. Tabata,et al.  Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell‒derived cardiomyocytes. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  Lil Pabon,et al.  Human ESC-Derived Cardiomyocytes Restore Function in Infarcted Hearts of Non-Human Primates , 2018, Nature Biotechnology.

[9]  D. Kraitchman,et al.  Matrix Metalloproteinase-2 Impairs Homing of Intracoronary Delivered Mesenchymal Stem Cells in a Porcine Reperfused Myocardial Infarction: Comparison With Intramyocardial Cell Delivery , 2018, Frontiers in Bioengineering and Biotechnology.

[10]  Alain Bel,et al.  Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction. , 2018, Journal of the American College of Cardiology.

[11]  Keiichi Fukuda,et al.  Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes , 2017, Stem cell reports.

[12]  Thomas Eschenhagen,et al.  Engineering Cardiac Muscle Tissue: A Maturating Field of Research. , 2017, Circulation research.

[13]  K. Cheng,et al.  Angiopellosis as an Alternative Mechanism of Cell Extravasation , 2017, Stem cells.

[14]  H. Reichenspurner,et al.  Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells , 2016, Science Translational Medicine.

[15]  M. Ohkura,et al.  Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts , 2016, Nature.

[16]  M. Suematsu,et al.  Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells. , 2016, Cell metabolism.

[17]  E. Tartour,et al.  Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. , 2015, European heart journal.

[18]  Kaytlyn A. Gerbin,et al.  Enhanced Electrical Integration of Engineered Human Myocardium via Intramyocardial versus Epicardial Delivery in Infarcted Rat Hearts , 2015, PloS one.

[19]  E. Marbán,et al.  Intracoronary Delivery of Self-Assembling Heart-Derived Microtissues (Cardiospheres) for Prevention of Adverse Remodeling in a Pig Model of Convalescent Myocardial Infarction , 2015, Circulation. Cardiovascular interventions.

[20]  K. Ishikawa.  Intracoronary injection of large stem cells: size matters. , 2015, Circulation. Cardiovascular interventions.

[21]  Minoru Ono,et al.  Safety and Efficacy of Autologous Skeletal Myoblast Sheets (TCD-51073) for the Treatment of Severe Chronic Heart Failure Due to Ischemic Heart Disease. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[22]  C. Don,et al.  Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts , 2014, Nature.

[23]  Y. Shiba,et al.  Electrical Integration of Human Embryonic Stem Cell-Derived Cardiomyocytes in a Guinea Pig Chronic Infarct Model , 2014, Journal of cardiovascular pharmacology and therapeutics.

[24]  R. Bonow,et al.  Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). , 2014, Journal of the American College of Cardiology.

[25]  M. Sever,et al.  Effects of Intracoronary CD34+ Stem Cell Transplantation in Nonischemic Dilated Cardiomyopathy Patients: 5-Year Follow-Up , 2013, Circulation research.

[26]  M. Suematsu,et al.  Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. , 2013, Cell stem cell.

[27]  Eduardo Marbán,et al.  Brief Report: Mechanism of Extravasation of Infused Stem Cells , 2012, Stem cells.

[28]  Atsushi Izawa,et al.  hESC-Derived Cardiomyocytes Electrically Couple and Suppress Arrhythmias in Injured Hearts , 2012, Nature.

[29]  B. Strauer,et al.  10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. , 2011, Journal of the American College of Cardiology.

[30]  James A Bankson,et al.  Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. , 2010, European heart journal.

[31]  Y. Shiba,et al.  Cardiac applications for human pluripotent stem cells. , 2009, Current pharmaceutical design.

[32]  Samuel Bernard,et al.  Evidence for Cardiomyocyte Renewal in Humans , 2008, Science.

[33]  W. Bloch,et al.  Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells. , 2008, Journal of molecular and cellular cardiology.

[34]  O. Alfieri,et al.  The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation , 2008, Circulation.

[35]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.

[36]  Ping Zhang,et al.  Radiolabeled Cell Distribution After Intramyocardial, Intracoronary, and Interstitial Retrograde Coronary Venous Delivery: Implications for Current Clinical Trials , 2005, Circulation.

[37]  David A. Williams,et al.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts , 2004, Nature.

[38]  Bernd Westphal,et al.  Autologous bone-marrow stem-cell transplantation for myocardial regeneration , 2003, The Lancet.

[39]  D. Pinkel,et al.  Two-color hybridization with high complexity chromosome-specific probes and a degenerate alpha satellite probe DNA allows unambiguous discrimination between symmetrical and asymmetrical translocations , 1991, Chromosoma.

[40]  C. Murry,et al.  Function Follows Form , 2021, Archiv des öffentlichen Rechts.

[41]  Takashi Aoi,et al.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.